Categories
News

Glucose Sensors Market 2020-2026 is Booming | Major Players – Novo Nordisk A/S, Nipro, InjexUK, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Ypsomed

Glucose Sensors Market

Being an influential, this Glucose Sensors Market research report will certainly help boost sales with new thinking, new skills, and innovative programs and tools. Glucose Sensors Market report is a precise study of the Healthcare industry which explains what the market definition, classifications, applications, engagements & global industry trends are. This global market research report encompasses a complete overview of the market, including an array of aspects such as product definition, segmentation based on various parameters & the prevailing vendor landscape. The market report deals with the market research of the Healthcare industry by considering several parameters that are affecting the business growth.

Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-glucose-sensors-market

Global glucose sensors market is set to witness a healthy CAGR of 19.4% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. The rise in the market value can be attributed to increasing cases of diabetes, and rising awareness, increasing geriatric population and increasing use of CGM devices.

Some of the major players operating in global glucose sensors market are AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, Smiths Group plc., Wockhardt Limited, Novo Nordisk A/S, Nipro, InjexUK, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Ypsomed, Mannkind Coroporation, Arkray, B. Braun Melsungen AG, Dexcom, Inc., Sannuo biosensor Ltd. and Bio-Rad Laboratories, Inc. among others.

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-glucose-sensors-market

Market Definition: Global Glucose Sensors Market

Glucose sensors are compressed analytical device or an element, integrating a biological or biologically derivative sensitive recognition section combined with physiochemical transducer. These sensors are important for oral glucose lowering medication or insulin treatment to deliver data of glucose concentrations in body. These sensors are pretty effective in monitoring the glucose level in human body.

According to the International Diabetes Federation, in 2017, diabetes caused 4 million deaths in which around 425 million adults were living with diabetes and this number will rise to 629 million by 2045. The number of adults with diabetes who are living in low- and middle-income countries is around 79%. Large numbers of people suffering from diabetes are in between 40 and 59 years of age.

Segmentation: Global Glucose Sensors Market

Glucose Sensor Market : By Product

  • Invasive Glucose Monitoring
  • Non Invasive Glucose Monitoring
  • Lab Based Glucose Monitoring
  • Self-Glucose Monitoring

Glucose Sensor Market : By Technology

  • Photo Acoustic Spectroscopy
  • Optical Coherence Tomography
  • Polarimetry
  • Fluorescence
  • MIR Spectroscopy
  • NIR Spectroscopy
  • Impedance Spectroscopy
  • Skin Suction Blister Technique
  • Sonophoresis
  • Reverse Iontophoresis

Glucose Sensor Market : By Component 

  • Sensors
  • Transmitters & Receivers
  • Integrated Insulin Pumps

Market Drivers : Global Glucose Sensors Market

  • Rising number of diabetes patients is driving the market growth
  • Increase in research and development investments is accelerating the market growth
  • Accurate and precise data of  the sensor is acting as a catalyst in market growth
  • Growing healthcare expenditure is increasing the market growth
  • Growing geriatric population is enhancing the market growth

Glucose Sensors Market Restraints

  • Strict rules and high cost of the sensors is hampering the market growth
  • Emerging Economies is hindering the market growth

Key Developments in the Glucose Sensors Market:

  • In June 2019, Nemaura Medical has received European approval to use needleless continuous glucose monitor on diabetic patients. This monitor was named as sugarBEAT. This device is paired with a smartphone app displaying glucose readings every five minutes. This approval would present a convenient alternate to the traditional methods used to monitor blood glucose to the patients
  • In March 2018, Medtronic plc announced that it has received U.S. Food and Drug Administration (FDA) approval for its Guardian Connect continuous glucose monitoring (CGM) system. It is the first smart standalone CGM system which assists people with diabetes to protect them from high and low glucose events. This  system would encourage people using multiple daily injections to control their diabetes

Features mentioned in the report

  1. Changing market dynamics of the industry
  2. To get a comprehensive overview of the Glucose Sensors market.
  3. Historical, current and projected market size in terms of volume and value
  4. In-depth market segmentation
  5. Competitive landscape of Glucose Sensors Market

To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-glucose-sensors-market

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail: [email protected]